Evolution of the NS3 and NS5B regions of the hepatitis C virus during disease recurrence after liver transplantation

American Journal of Transplantation

Volumn 7, Issue 9, 2007, Pages 2172-2179

  Massaguer, A ^a   Ramirez S ^a   Carrion J A ^a   Gonzalez P ^a   Sanchez Tapias J M ^a   Forns, X ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

Genetic evolution; Hepatitis C virus; Transplantation

Indexed keywords

NONSTRUCTURAL PROTEIN 3; NS5B PROTEIN; PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONSENSUS SEQUENCE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FIBROSIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; LIVER BIOPSY; LIVER TRANSPLANTATION; MALE; MOLECULAR EVOLUTION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RECURRENT DISEASE; STRUCTURAL GENE; TREATMENT OUTCOME; UNINDEXED SEQUENCE; VIREMIA; VIRUS LOAD;

EID: 34547842735     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2007.01894.x     Document Type: Article

References (50)

1. Prieto M, Berenguer M, Rayon JM et al. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: Relationship with rejection episodes. Hepatology 1999 29:250 256.
2. Berenguer M, Ferrell L, Watson J et al. HCV-related fibrosis progression following liver transplantation: Increase in recent years. J Hepatology 2000 32:673 684.
3. Garcia-Retortillo M, Forns X, Llovet JM et al. Hepatitis C recurrence is more severe after living donor compared to cadaveric liver transplantation. Hepatology 2004 40:699 707.
4. Garcia-Retortillo M, Forns X, Feliu A et al. Hepatitis C virus kinetics during and immediately after liver transplantation. Hepatology 2002 35:680 687.
5. Dahari H, Feliu A, Garcia-Retortillo M, Forns X, Neumann AU. Second hepatitis C replication compartment indicated by viral dynamics during liver transplantation. J Hepatology 2005 42:491 498.
6. Feliu A, Gay E, Garcia-Retortillo M, Saiz JC, Forns X. Evolution of hepatitis C virus quasispecies immediately following liver transplantation. Liver Transpl 2004 10:1131 1139.
7. Manez R, Mateo R, Tabasco J, Kusne S, Starzl TE, Duquesnoy RJ. The influence of hla donor-recipient compatibility on the recurrence of hbv and hcv hepatitis after liver-transplantation. Transplantation 1995 59:640 642.
8. Charlton M, Seaberg E, Wiesner R et al. Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology 1998 28:823 830.
9. Berenguer M, Prieto M, Cordoba J et al. Early development of chronic active hepatitis in recurrent hepatitis C virus infection after liver transplantation: Association with treatment of rejection. J Hepatology 1998 28:756 763.
10. Sanchez-Fueyo A, Gimenez-Barcons M, Puig-Basagoiti F et al. Influence of the dynamics of the hypervariable region 1 of hepatitis C virus (HCV) on the histological severity of HCV recurrence after liver transplantation. J Med Virology 2001 65:266 275.
11. Forman LM, Lewis JD, Berlin JA, Feldman HI, Lucey MR. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002 122:889 896.
12. Gretch DR, Polyak SJ, Wilson JJ, Carithers RL, Perkins JD, Corey L. Tracking hepatitis C virus quasispecies major and minor variants in symptomatic and asymptomatic liver transplant recipients. Journal of Virology 1996 70:7622 7631.
13. Lawal Z, Petrik J, Wong VS, Alexander GJM, Allain JP. Hepatitis C virus genomic variability in untreated and immunosuppressed patients. Virology 1997 228:107 111.
14. Pessoa MG, Bzowej N, Berenguer M et al. Evolution of hepatitis C virus quasispecies in patients with severe cholestatic hepatitis after liver transplantation. Hepatology 1999 30:1513 1520.
15. Gigou M, Roque-Afonso AM, Falissard B, Penin F, Dussaix E, Feray C. Genetic clustering of hepatitis C virus strains and severity of recurrent hepatitis after liver transplantation. J Virology 2001 75:11292 11297.
16. Lopez-Labrador FX, Bracho MA, Berenguer M et al. Genetic similarity of hepatitis C virus and fibrosis progression in chronic and recurrent infection after liver transplantation. Journal of Viral Hepatitis 2006 13:104 115.
17. De Francesco R, Tomei L, Altamura S, Summa V, Migliaccio G. Approaching a new era for hepatitis C virus therapy: Inhibitors of the NS3-4 A serine protease and the NS5B RNA-dependent RNA polymerase. Antiviral Res 2003 58:1 16.
18. Fischmann TO, Weber PC. Peptidic inhibitors of the hepatitis C virus serine protease within non-structural protein 3. Curr Pharm Des 2002 8:2533 2540.
19. Lamarre D, Anderson PC, Bailey M et al. An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus. Nature 2003 426:186 189.
20. Lin K, Perni RB, Kwong AD, Lin C. VX-950, a novel hepatitis C virus (HCV) NS34 A protease inhibitor, exhibits potent antiviral activities in HCV replicon cells. Antimicrob Agents Chemother 2006 50:1813 1822.
21. Scheuer PJ. The Nomenclature of Chronic Hepatitis - Time for A Change. JHepatol 1995 22:112 114.
22. Neumann UP, Berg T, Bahra M et al. Fibrosis progression after liver transplantation in patients with recurrent hepatitis C. J Hepatol 2004 41:830 836.
23. Blasco A, Forns X, Carrion JA et al. Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation. Hepatology 2006 43:492 499.
24. Pawlotsky JM. Molecular diagnosis of viral hepatitis. Gastroenterology 2002 122:1554 1568.
25. Kato N, Hijikata M, Ootsuyama Y et al. Molecular-cloning of the human hepatitis-C virus genome from Japanese patients with non-a, non-b hepatitis. Proceedings of the National Academy of Sciences of the United States of America 1990 87:9524 9528.
26. Qin WP, Yamashita T, Shirota Y, Lin Y, Wei WX, Murakami S. Mutational analysis of the structure and functions of hepatitis C virus RNA-dependent RNA polymerase. Hepatology 2001 33:728 737.
27. Watanabe K, Yoshioka K, Yano M et al. Mutations in the nonstructural region 5B of hepatitis C virus genotype 1b: Their relation to viral load, response to interferon, and the nonstructural region 5 A. J Med Virol 2005 75:504 512.
28. Puig-Basagoiti F, Saiz JC, Forns X et al. Influence of the genetic heterogeneity of the ISDR and PePHD regions of hepatitis C virus on the response to interferon therapy in chronic hepatitis C. Journal Med Virol 2001 65:35 44.
29. Kumar S, Tamura K, Nei M. Mega - molecular evolutionary genetics analysis software for microcomputers. Computer Applications in the Biosciences 1994 10:189 191.
30. Wang H, Eckels DD. Mutations in immunodominant T cell epitopes derived from the nonstructural 3 protein of hepatitis C virus have the potential for generating escape variants that may have important consequences for T cell recognition. J Immunol 1999 162:4177 4183.
31. Day CL, Lauer GM, Robbins GK et al. Broad specificity of virus-specific CD4(+) T-helper-cell responses in resolved hepatitis C virus infection. J Virol 2002 76:12584 12595.
32. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997 349:825 832.
33. Berenguer M, Prieto M, San Juan F et al. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients. Hepatology 2002 36:202 210.
34. De Francesco R, Pessi A, Steinkuhler C. The hepatitis C virus NS3 proteinase: Structure and function of a zinc-containing serine proteinase. Antivir Ther 1998 3:99 109.
35. Penin F, Dubuisson J, Rey FA, Moradpour D, Pawlotsky JM. Structural biology of hepatitis C virus. Hepatology 2004 39:5 19.
36. Lohmann V, Korner F, Koch JO, Herian U, Theilmann L, Bartenschlager R. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 1999 285:110 113.
37. Cheney IW, Naim S, Lai VCH et al. Mutations in NS5B polymerase of hepatitis C virus: Impacts on in vitro enzymatic activity and viral RNA replication in the subgenomic replicon cell culture. Virology 2002 297:298 306.
38. Lohmann V, Hoffmann S, Herian U, Penin F, Bartenschlager R. Viral and cellular determinants of hepatitis C virus RNA replication in cell culture. J Virol 2003 77:3007 3019.
39. Sarrazin C, Mihm U, Herrmann E et al. Clinical significance of in vitro replication-enhancing mutations of the hepatitis C virus (HCV) replicon in patients with chronic HCV infection. J Infect Dis 2005 192:1710 1719.
40. Grakoui A, Shoukry NH, Woollard DJ et al. HCV persistence and immune evasion in the absence of memory T cell help. Science 2003 302:659 662.
41. zur Wiesch JS, Lauer GM, Day CL et al. Broad repertoire of the CD4(+) th cell response in spontaneously controlled hepatitis C virus infection includes dominant and highly promiscuous epitopes. J Immunol 2005 175:3603 3613.
42. Weston SJ, Leistikow RL, Reddy KR et al. Reconstitution of hepatitis C virus-specific T-cell-mediated immunity after liver transplantation. Hepatology 2005 41:72 81.
43. Rosen HR, Hinrichs DJ, Gretch DR et al. Association of multispecific CD4(+) response to hepatitis C and severity of recurrence after liver transplantation. Gastroenterology 1999 117:926 932.
44. Booth JCL, Kumar U, Webster D, Monjardino J, Thomas HC. Comparison of the rate of sequence variation in the hypervariable region of E2/NS1 region of hepatitis C virus in normal and hypogammaglobulinemic patients. Hepatology 1998 27:223 227.
45. Gaud U, Langer B, Petropoulou T, Thomas HC, Karayiannis P. Changes in hypervariable region 1 of the envelope 2 glycoprotein of hepatitis C virus in children and adults with humoral immune defects. J Med Virol 2003 69:350 356.
46. Moya A, Holmes EC, Gonzalez-Candelas F. The population genetics and evolutionary epidemiology of RNA viruses. Nature Reviews Microbiology 2004 2:279 288.
47. Okura I, Horiike N, Michitaka K, Onji M. Effect of mutation in the hepatitis C virus nonstructural 5B region on HCV replication. J Gastroenterol 2004 39:449 454.
48. Hamano K, Sakamoto N, Enomoto N et al. Mutations in the NS5B region of the hepatitis C virus genome correlate with clinical outcomes of interferon-alpha plus ribavirin combination therapy. J Gastroenterol Hepatol 2005 20:1401 1409.
49. Lopez-Labrador FX, Berenguer M, Sempere A et al. Genetic variability of hepatitis C virus NS3 protein in human leukocyte antigen-A2 liver transplant recipients with recurrent hepatitis C. Liver Transpl 2004 10:217 227.
50. Rosen HR, Marousek G, Chou SW. A longitudinal analysis of T-cell epitope-coding regions of hepatitis C virus after liver transplantation. Transplantation 2002 74:209 216.